MGC Diagnostics

Global manufacturer of diagnostic, testing and monitoring equipment, accessories, supplies and service solutions for the cardiorespiratory health market.

Transaction Overview

  • Represented MGC Diagnostics Corporation (“MGCD”) on its sale to Altus Capital Partners, Inc. (“Altus”).
  • MGC Diagnostics is a leading global medical technology company dedicated to cardiorespiratory health solutions.

Key Observations

  • MGC Diagnostics was exploring strategic alternatives to support the next phase of its growth strategy, while also providing shareholders immediate liquidity.

Drivers of Interest

  • Differentiated Equipment/Technology and Recurring Revenue and Services.
  • Highly Experienced Management Team With Impressive Track Record.
  • Convergence of Multiple Industry Growth Drivers.
  • Unique Competitive Position.
  • Substantial Growth Opportunity in Upstream Cardiorespiratory Market.
  • Credible and Proven Sales and Marketing Initiatives Driving Growth.
  • Best-of-Breed Diagnostic Software.
Hennepin Partners LLC